Search by Drug Name or NDC

    NDC 71428-0002-60 Fluocinolone Acetonide 0.1 mg/mL Details

    Fluocinolone Acetonide 0.1 mg/mL

    Fluocinolone Acetonide is a TOPICAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glasshouse Pharmaceuticals Limited Canada. The primary component is FLUOCINOLONE ACETONIDE.

    Product Information

    NDC 71428-0002
    Product ID 71428-002_0e88e5a3-cb33-ca6a-e063-6294a90a9aec
    Associated GPIs 90550055102005
    GCN Sequence Number 007612
    GCN Sequence Number Description fluocinolone acetonide SOLUTION 0.01 % TOPICAL
    HIC3 Q5P
    HIC3 Description TOPICAL ANTI-INFLAMMATORY STEROIDAL
    GCN 31360
    HICL Sequence Number 002896
    HICL Sequence Number Description FLUOCINOLONE ACETONIDE
    Brand/Generic Generic
    Proprietary Name Fluocinolone Acetonide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fluocinolone Acetonide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route TOPICAL
    Active Ingredient Strength 0.1
    Active Ingredient Units mg/mL
    Substance Name FLUOCINOLONE ACETONIDE
    Labeler Name Glasshouse Pharmaceuticals Limited Canada
    Pharmaceutical Class Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209596
    Listing Certified Through 2025-12-31

    Package

    NDC 71428-0002-60 (71428000260)

    NDC Package Code 71428-002-60
    Billing NDC 71428000260
    Package 1 BOTTLE in 1 CARTON (71428-002-60) / 60 mL in 1 BOTTLE
    Marketing Start Date 2018-06-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.33847
    Pricing Unit ML
    Effective Date 2022-11-23
    NDC Description FLUOCINOLONE 0.01% SOLUTION
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2022-11-23
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis